Arcellx (ACLX) Accumulated Depreciation (2021 - 2025)
Arcellx (ACLX) recorded quarterly Accumulated Depreciation of $15.7 million in Q4 2025, up 66.74% quarter-over-quarter from $9.4 million in Q4 2024, and up 66.74% on a YoY basis from $9.4 million in Q4 2024.
Arcellx (ACLX) Accumulated Depreciation (2021 - 2025) Analysis & Trends
Arcellx's Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $15.7 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 66.74% year-over-year to $15.7 million; the TTM figure through Dec 2025 stood at $15.7 million (up 66.74% YoY), while the FY2025 annual figure was $15.7 million, up 66.74% from the prior year.
- Accumulated Depreciation was $15.7 million for Q4 2025 at Arcellx, up from $9.4 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $15.7 million in Q4 2025 to a low of $2.2 million in Q4 2021.
- Historically, Accumulated Depreciation has averaged $7.2 million across 5 years, with a median of $5.3 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Accumulated Depreciation soared 51.78% in 2023, then jumped 79.78% in 2024.
- A 5-year view of Accumulated Depreciation shows it stood at $2.2 million in 2021, then soared by 60.08% to $3.5 million in 2022, then soared by 51.78% to $5.3 million in 2023, then surged by 79.78% to $9.4 million in 2024, then jumped by 66.74% to $15.7 million in 2025.
- The last three Accumulated Depreciation figures came in at $15.7 million (Q4 2025), $9.4 million (Q4 2024), and $5.3 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.75 Mn |
| Dec 31, 2024 | 9.44 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Dec 31, 2021 | 2.16 Mn |